These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12012150

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV, Sternić NM, Filipović SR, Vojvodić NM, Kostić VS.
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [Abstract] [Full Text] [Related]

  • 3. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.
    Wolk SI, Douglas CJ.
    J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
    Sitburana O, Rountree S, Ondo WG.
    J Neurol Sci; 2008 Sep 15; 272(1-2):77-82. PubMed ID: 18556024
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M, Courtet P, Castelnau D.
    Encephale; 1996 Sep 15; 22(1):53-63. PubMed ID: 8681876
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH, Trieschmann ME, Okun MS.
    Mov Disord; 2005 Jan 15; 20(1):104-5. PubMed ID: 15390047
    [Abstract] [Full Text] [Related]

  • 13. Othello syndrome in patients with Parkinson's disease.
    Georgiev D, Danieli A, Ocepek L, Novak D, Zupancic-Kriznar N, Trost M, Pirtosek Z.
    Psychiatr Danub; 2010 Mar 15; 22(1):94-8. PubMed ID: 20305599
    [Abstract] [Full Text] [Related]

  • 14. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb 15; 11(57):1-6. PubMed ID: 11985366
    [Abstract] [Full Text] [Related]

  • 15. Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.
    Wang MT, Lian PW, Yeh CB, Yen CH, Ma KH, Chan AL.
    Mov Disord; 2011 Aug 01; 26(9):1663-9. PubMed ID: 21630354
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Parkinson's disease: drug-induced psychiatric states.
    Factor SA, Molho ES, Podskalny GD, Brown D.
    Adv Neurol; 1995 Aug 01; 65():115-38. PubMed ID: 7872135
    [Abstract] [Full Text] [Related]

  • 18. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC, Dahmen MM, Makos M, Lea JW, Carver LJ, Rasu RS.
    Ann Pharmacother; 2009 Sep 01; 43(9):1426-32. PubMed ID: 19690226
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.